## Management of CIN 2 in a Young Woman **Key Point:** CIN 2 (cervical intraepithelial neoplasia grade 2) requires **excisional treatment** with histopathological assessment of margins, regardless of age or HPV status. This is the standard of care per ASCCP and FIGO guidelines. ### Why Excision (LEEP/Cold Knife Conization) is Correct: - **CIN 2 has a 40–50% risk of progression to invasive cancer** if left untreated - **Excisional procedures serve dual purpose:** therapeutic (removes lesion) + diagnostic (allows margin assessment and exclusion of invasive disease) - **Margin status is critical:** negative margins reduce recurrence risk to <5%; positive margins increase recurrence to 20–30% - **HPV-18 status:** Although HPV-18 is associated with adenocarcinoma, CIN 2 with HPV-18 still requires excision - **Age consideration:** At 35 years, fertility preservation is possible post-excision; hysterectomy is NOT indicated for CIN ### Why Other Options Are Incorrect: **Option 0 (Observation):** - CIN 2 is NOT managed conservatively in non-pregnant women - Observation is reserved only for CIN 1 in certain low-risk scenarios - Waiting risks progression to invasive disease **Option 2 (Radical Hysterectomy):** - Hysterectomy is indicated only for **invasive cervical cancer (stage IA1 or higher)** - CIN is a precancerous lesion, not invasive cancer - Hysterectomy is unnecessary and denies fertility **Option 3 (Topical 5-FU):** - 5-FU is used for **vaginal intraepithelial neoplasia (VaIN)**, not cervical lesions - No role in CIN 2 management - Does not provide histological assessment ## Clinical Pearl: **ASCCP 2019 & FIGO Guidelines:** All CIN 2 lesions require excisional treatment. Observation is NOT an option for non-pregnant women with CIN 2, even if HPV-positive. Post-treatment surveillance includes repeat cytology at 6 and 12 months, and HPV testing at 12 months.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.